Dynavax Technologies Stock Fundamentals
| DVAX Stock | USD 12.36 0.19 1.56% |
Dynavax Technologies fundamentals help investors to digest information that contributes to Dynavax Technologies' financial success or failures. It also enables traders to predict the movement of Dynavax Stock. The fundamental analysis module provides a way to measure Dynavax Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dynavax Technologies stock.
At this time, Dynavax Technologies' Selling General Administrative is fairly stable compared to the past year. Net Income From Continuing Ops is likely to rise to about 64.2 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 3.7 M in 2024. Dynavax | Select Account or Indicator |
Dynavax Technologies Company Operating Margin Analysis
Dynavax Technologies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Dynavax Technologies Operating Margin | 0.15 % |
Most of Dynavax Technologies' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dynavax Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Dynavax Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Dynavax Technologies has an Operating Margin of 0.1524%. This is 100.43% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The operating margin for all United States stocks is 102.77% lower than that of the firm.
Dynavax Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dynavax Technologies's current stock value. Our valuation model uses many indicators to compare Dynavax Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dynavax Technologies competition to find correlations between indicators driving Dynavax Technologies's intrinsic value. More Info.Dynavax Technologies is rated # 4 in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Dynavax Technologies' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dynavax Technologies' earnings, one of the primary drivers of an investment's value.Dynavax Technologies' Earnings Breakdown by Geography
Dynavax Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dynavax Technologies' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics of similar companies.Dynavax Technologies is currently under evaluation in operating margin category among its peers.
Dynavax Technologies ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Dynavax Technologies' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Dynavax Technologies' managers, analysts, and investors.Environmental | Governance | Social |
Dynavax Fundamentals
| Return On Equity | 0.0318 | ||||
| Return On Asset | -0.0038 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 1.06 B | ||||
| Shares Outstanding | 131.46 M | ||||
| Shares Owned By Insiders | 0.33 % | ||||
| Shares Owned By Institutions | 99.67 % | ||||
| Number Of Shares Shorted | 18.84 M | ||||
| Price To Earning | 6.95 X | ||||
| Price To Book | 2.32 X | ||||
| Price To Sales | 6.13 X | ||||
| Revenue | 232.28 M | ||||
| Gross Profit | 448.22 M | ||||
| EBITDA | 9.67 M | ||||
| Net Income | (6.39 M) | ||||
| Cash And Equivalents | 518.17 M | ||||
| Cash Per Share | 4.10 X | ||||
| Total Debt | 256.91 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 2.77 X | ||||
| Book Value Per Share | 5.19 X | ||||
| Cash Flow From Operations | 100.56 M | ||||
| Short Ratio | 8.88 X | ||||
| Earnings Per Share | 0.15 X | ||||
| Target Price | 24.6 | ||||
| Number Of Employees | 408 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 1.6 B | ||||
| Total Asset | 997.1 M | ||||
| Retained Earnings | (930.58 M) | ||||
| Working Capital | 796.92 M | ||||
| Current Asset | 199.95 M | ||||
| Current Liabilities | 28.79 M | ||||
| Net Asset | 997.1 M |
About Dynavax Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 60.3 M | 31 M | |
| Total Revenue | 232.3 M | 243.9 M | |
| Cost Of Revenue | 50.2 M | 52.1 M | |
| Stock Based Compensation To Revenue | 0.18 | 0.17 | |
| Sales General And Administrative To Revenue | 0.66 | 0.63 | |
| Research And Ddevelopement To Revenue | 0.24 | 0.22 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 1.80 | 1.71 | |
| Ebit Per Revenue | (0.16) | (0.17) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.